Mortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort study.
<h4>Background</h4>The increased mortality in HCV-infected individuals partly stems from viral damage to the liver and partly from risk-taking behaviours. We examined mortality in patients who cleared their HCV-infection, comparing it to that of the general population. We also addressed...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a02b53eb3d3a47378b8c1e39390fcb11 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a02b53eb3d3a47378b8c1e39390fcb11 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a02b53eb3d3a47378b8c1e39390fcb112021-11-18T06:50:04ZMortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort study.1932-620310.1371/journal.pone.0022476https://doaj.org/article/a02b53eb3d3a47378b8c1e39390fcb112011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21789259/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>The increased mortality in HCV-infected individuals partly stems from viral damage to the liver and partly from risk-taking behaviours. We examined mortality in patients who cleared their HCV-infection, comparing it to that of the general population. We also addressed the question whether prognosis differed according to age, substance abuse (alcohol abuse and injection drug use) and comorbidity.<h4>Methodology/principal findings</h4>Patients with cleared HCV-infection were categorized into one of 8 groups according to age (20-39 years or 40-69 years) and patient characteristics (no substance abuse/no comorbidity; substance abuse/no comorbidity; no substance abuse/comorbidity; and substance abuse/comorbidity). For each patient, 4 age- and gender-matched individuals without substance abuse or comorbidity were selected from the general population, comprising a total of 8 comparison cohorts. We analyzed 10-year survival and used stratified Cox Regression analysis to compute mortality rate ratios (MRRs), comparing mortality between the 8 patient groups and the comparison cohorts, adjusting for personal income. Among patients without substance abuse or comorbidity, those aged 40-69 years had the same mortality as the comparison cohort (10-year survival: 95% (95% confidence interval [CI]: 93%-97%), MRR: 1.3 (95% CI: 0.8-2.3)), whereas those aged 20-39 years had higher mortality than the comparison cohort (10-year survival: 93% versus 99%, MRR: 5.7 (95% CI: 2.3-14.0). For both age categories, substance abuse and comorbidity decreased survival and increased MRRs. Patients aged 40-69 years with substance abuse and comorbidity suffered from substantial mortality (MRR: 12.5 (95% CI: 5.1-30.6)).<h4>Conclusions</h4>Mortality in patients aged 40-69 years with cleared HCV-infection is comparable to individuals without HCV, provided they have no substance abuse or comorbidity. Any substance abuse and/or comorbidity not captured in the registries used for our study could explain the increased mortality in patients aged 20-39 years without documented substance abuse or comorbidity.Lars Haukali OmlandPeer Brehm ChristensenHenrik KrarupPeter JepsenNina WeisHenrik Toft SørensenNiels ObelDANVIR Cohort StudyPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 7, p e22476 (2011) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Lars Haukali Omland Peer Brehm Christensen Henrik Krarup Peter Jepsen Nina Weis Henrik Toft Sørensen Niels Obel DANVIR Cohort Study Mortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort study. |
description |
<h4>Background</h4>The increased mortality in HCV-infected individuals partly stems from viral damage to the liver and partly from risk-taking behaviours. We examined mortality in patients who cleared their HCV-infection, comparing it to that of the general population. We also addressed the question whether prognosis differed according to age, substance abuse (alcohol abuse and injection drug use) and comorbidity.<h4>Methodology/principal findings</h4>Patients with cleared HCV-infection were categorized into one of 8 groups according to age (20-39 years or 40-69 years) and patient characteristics (no substance abuse/no comorbidity; substance abuse/no comorbidity; no substance abuse/comorbidity; and substance abuse/comorbidity). For each patient, 4 age- and gender-matched individuals without substance abuse or comorbidity were selected from the general population, comprising a total of 8 comparison cohorts. We analyzed 10-year survival and used stratified Cox Regression analysis to compute mortality rate ratios (MRRs), comparing mortality between the 8 patient groups and the comparison cohorts, adjusting for personal income. Among patients without substance abuse or comorbidity, those aged 40-69 years had the same mortality as the comparison cohort (10-year survival: 95% (95% confidence interval [CI]: 93%-97%), MRR: 1.3 (95% CI: 0.8-2.3)), whereas those aged 20-39 years had higher mortality than the comparison cohort (10-year survival: 93% versus 99%, MRR: 5.7 (95% CI: 2.3-14.0). For both age categories, substance abuse and comorbidity decreased survival and increased MRRs. Patients aged 40-69 years with substance abuse and comorbidity suffered from substantial mortality (MRR: 12.5 (95% CI: 5.1-30.6)).<h4>Conclusions</h4>Mortality in patients aged 40-69 years with cleared HCV-infection is comparable to individuals without HCV, provided they have no substance abuse or comorbidity. Any substance abuse and/or comorbidity not captured in the registries used for our study could explain the increased mortality in patients aged 20-39 years without documented substance abuse or comorbidity. |
format |
article |
author |
Lars Haukali Omland Peer Brehm Christensen Henrik Krarup Peter Jepsen Nina Weis Henrik Toft Sørensen Niels Obel DANVIR Cohort Study |
author_facet |
Lars Haukali Omland Peer Brehm Christensen Henrik Krarup Peter Jepsen Nina Weis Henrik Toft Sørensen Niels Obel DANVIR Cohort Study |
author_sort |
Lars Haukali Omland |
title |
Mortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort study. |
title_short |
Mortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort study. |
title_full |
Mortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort study. |
title_fullStr |
Mortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort study. |
title_full_unstemmed |
Mortality among patients with cleared hepatitis C virus infection compared to the general population: a Danish nationwide cohort study. |
title_sort |
mortality among patients with cleared hepatitis c virus infection compared to the general population: a danish nationwide cohort study. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2011 |
url |
https://doaj.org/article/a02b53eb3d3a47378b8c1e39390fcb11 |
work_keys_str_mv |
AT larshaukaliomland mortalityamongpatientswithclearedhepatitiscvirusinfectioncomparedtothegeneralpopulationadanishnationwidecohortstudy AT peerbrehmchristensen mortalityamongpatientswithclearedhepatitiscvirusinfectioncomparedtothegeneralpopulationadanishnationwidecohortstudy AT henrikkrarup mortalityamongpatientswithclearedhepatitiscvirusinfectioncomparedtothegeneralpopulationadanishnationwidecohortstudy AT peterjepsen mortalityamongpatientswithclearedhepatitiscvirusinfectioncomparedtothegeneralpopulationadanishnationwidecohortstudy AT ninaweis mortalityamongpatientswithclearedhepatitiscvirusinfectioncomparedtothegeneralpopulationadanishnationwidecohortstudy AT henriktoftsørensen mortalityamongpatientswithclearedhepatitiscvirusinfectioncomparedtothegeneralpopulationadanishnationwidecohortstudy AT nielsobel mortalityamongpatientswithclearedhepatitiscvirusinfectioncomparedtothegeneralpopulationadanishnationwidecohortstudy AT danvircohortstudy mortalityamongpatientswithclearedhepatitiscvirusinfectioncomparedtothegeneralpopulationadanishnationwidecohortstudy |
_version_ |
1718424370057052160 |